Scott Boyd to Seroepidemiologic Studies
This is a "connection" page, showing publications Scott Boyd has written about Seroepidemiologic Studies.
Connection Strength
0.109
-
Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. JAMA Netw Open. 2021 07 01; 4(7):e2116572.
Score: 0.073
-
Efficient Identification of High-Titer Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antibody Plasma Samples by Pooling Method. Arch Pathol Lab Med. 2021 10 01; 145(10):1221-1227.
Score: 0.019
-
Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 09; 42(9):1053-1059.
Score: 0.018